SCHEMBL10673241

SCHEMBL10673241

CCC(CC)OC(=O)CCCCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.53
MAPT P10636 4/20 0.53
CYP1A2 P05177 3/20 0.51
LMNA P02545 6/20 0.50
TSHR P16473 5/20 0.50
GMNN O75496 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HSP90AA1 P07900 2/20 0.50
BLM P54132 2/20 0.50
NR1H4 Q96RI1 2/20 0.50
TP53 P04637 1/20 0.50
CYP2C9 P11712 1/20 0.50
HIF1A Q16665 1/20 0.50
GLA P06280 1/20 0.49
PMP22 Q01453 1/20 0.49
AKR1B1 P15121 1/20 0.48
PPARG P37231 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28367234 0.98 MAPK1 (0.56) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL27824020 0.98 MAPK1 (0.56) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL28371322 0.98 MAPK1 (0.56) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL10551517 0.96 TSHR (0.54) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL247870 0.91 MAPK1 (0.61) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL1981434 0.90 MAPT (0.62) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL250209 0.89 MAPK1 (0.64) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL249092 0.89 MAPK1 (0.64) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL7783714 0.89 MAPK1 (0.64) MAPK1MAPTCYP1A2LMNATSHR
SCHEMBL3212483 0.89 MAPK1 (0.51) MAPK1MAPTCYP1A2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139954-A Lubricating oil composition for hybrid vehicle 雪佛龙日本有限公司 2024-06-04 CN claimed
CN-118139954-A Lubricating oil composition for hybrid vehicle 雪佛龙日本有限公司 2024-06-04 CN disclosed
CN-110914334-A Polyester copolymer 阿凡田知识中心有限公司 2020-03-24 CN disclosed
EP-3252861-B1 NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME MITSUBISHI CHEM CORP (JP) 2019-06-26 EP disclosed
CN-108607562-A Catalyst and preparation method and application for hexanedioic acid dialkyl ester hexylene glycol 中溶科技股份有限公司 2018-10-02 CN disclosed
EP-3252861-A1 NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME Mitsubishi Chemical Corporation (JP) 2017-12-06 EP disclosed
US-20170324116-A1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2017-11-09 US disclosed
US-20170001944-A1 CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-01-05 US disclosed
US-20170001944-A1 CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-01-05 US disclosed
CN-102655748-B Liquid suspension concentrate preparaton containing benzene flumetsulam BASF SE (DE) 2015-11-25 CN disclosed
WO-2015084265-A1 CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-11 WO disclosed
CN-102651971-B Liquid suspension concentrate formulations containing saflufenacil and glyphosate BASF SE 2015-05-13 CN disclosed
CN-102655748-A Liquid suspension concentrate formulations containing saflufenacil BASF SE 2012-09-05 CN disclosed
CN-102651971-A Liquid suspension concentrate formulations containing saflufenacil and glyphosate BASF SE 2012-08-29 CN disclosed
CN-102311839-A Trunk piston engine lubricating oil compositions CHEVRON ORONITE TECHNOLOGY BV 2012-01-11 CN disclosed
CN-102176821-A Liquid aqueous crop protection formulations BASF SE 2011-09-07 CN disclosed
CN-102176820-A Liquid crop protection formulations containing pyraclostrobin BASF SE 2011-09-07 CN disclosed
US-4780526-A POLYMERIZING CYCLOPENTADIENE WITH ALDEHYDE USING BASIC CATALYST ASHLAND OIL, INC. (US) 1988-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001944-A1 CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID MUC1, ADIPOR1, FASN MAPK1 2424/4885MAPT 4414/4885CYP1A2 647/4885
US-20170324116-A1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME KCNN2, KCNE1, KCNN1 MAPK1 2467/4885MAPT 3325/4885CYP1A2 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.